Desipramine improves upper airway collapsibility and reduces OSA severity in patients with minimal muscle compensation
Year: 2016
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Abstract: We recently demonstrated that desipramine reduces the sleep-related loss of upper airway dilator muscle activity and reduces pharyngeal collapsibility in healthy humans without obstructive sleep apnoea (OSA). The aim of the present physiological study was to determine the effects of desipramine on upper airway collapsibility and apnoea–hypopnea index (AHI) in OSA patients. A placebo-controlled, double-blind, randomised crossover trial in 14 OSA patients was performed. Participants received treatment or placebo in randomised order before sleep. Pharyngeal collapsibility (critical collapsing pressure of the upper airway ( P crit )) and ventilation under both passive ( V′ 0,passive ) and active ( V′ 0,active ) upper airway muscle conditions were evaluated with continuous positive airway pressure (CPAP) manipulation. AHI was quantified off CPAP. Desipramine reduced active P crit (median (interquartile range) −5.2 (4.3) cmH 2 O on desipramine versus −1.9 (2.7) cmH 2 O on placebo; p=0.049) but not passive P crit (−2.2 (3.4) versus −0.7 (2.1) cmH 2 O; p=0.135). A greater reduction in AHI occurred in those with minimal muscle compensation (defined as V′ 0,active − V′ 0,passive ) on placebo (r=0.71, p=0.009). The reduction in AHI was driven by the improvement in muscle compensation (r=0.72, p=0.009). In OSA patients, noradrenergic stimulation with desipramine improves pharyngeal collapsibility and may be an effective treatment in patients with minimal upper airway muscle compensation.
Source: European Respiratory Journal
Language: English
Subfield: Physiology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Awards: G2496518617, Mechanisms of Arousal in Sleep Apnea, Harvard Clinical and Translational Science Center (UL1), Sleep apnea phenotyping for personalized therapy using clinical polysomnography, Quantifying the ventilatory control contribution to obstructive sleep apnoea using clinical polysomnography, Obesity and sleep apnea, Inducing Slow Wave Sleep to Treat Obstructive Sleep Apnea, Reducing ventilatory instability and sleep apnea in patients with heart failure, The effects of sedatives in sleep apnoea - physiological mechanisms and therapeutic utility, Determination of the site of pharyngeal collapse in Obstructive Sleep Apnea patients from snoring sounds, Predicting response to non-PAP therapies in OSA using PSG-derived endotypes
OpenAlex ID: W2529466875
